ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Julio C. Vasquez
Frank A. Baciewicz, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasquez, J. C.
Right arrow Articles by Baciewicz, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasquez, J. C.
Right arrow Articles by Baciewicz, F. A., Jr
Related Collections
Right arrow Extracorporeal circulation

Ann Thorac Surg 2002;74:2177-2179
© 2002 The Society of Thoracic Surgeons


Case report

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery

Julio C. Vasquez, MDa, Anna Vichiendilokkul, PharmDb, Syed Mahmood, MDc, Frank A. Baciewicz, Jr, MDa*

a Department of Cardiothoracic Surgery, Harper University Hospital, Wayne State University, Detroit, Michigan, USA
b Department of Pharmacy, Harper University Hospital, Wayne State University, Detroit, Michigan, USA
c Department of Cardiology, Harper University Hospital, Wayne State University, Detroit, Michigan, USA

Accepted for publication July 10, 2002.

* Address reprint requests to Dr Baciewicz, Department of Cardiothoracic Surgery, Harper University Hospital, 3990 John R, Suite 2101, Detroit, MI 48201, USA.
e-mail: fbaciewi{at}dmc.org

Heparin is the standard agent used for systemic anticoagulation during cardiopulmonary bypass in cardiac operations. Alternatives are needed when patients with heparin-induced thrombocytopenia type II are encountered. We present a patient with a clinical picture of heparin-induced thrombocytopenia type II who was effectively anticoagulated with bivalirudin, a direct thrombin inhibitor, during cardiopulmonary bypass for a cardiac operation.




This article has been cited by other articles:


Home page
ChestHome page
T. E. Warkentin, A. Greinacher, A. Koster, and A. M. Lincoff
Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 340S - 380S.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
A. Vincentelli, B. Jude, and S. Belisle
Antithrombotic therapy in cardiac surgery: [Traitement antithrombotique en chirurgie cardiaque].
Can J Anesth, June 1, 2006; 53(6_suppl): S89 - S102.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Hassell
The Management of Patients With Heparin-Induced Thrombocytopenia Who Require Anticoagulant Therapy
Chest, February 1, 2005; 127(2_suppl): 1S - 8S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. H. Matthai Jr
Thrombocytopenia in Cardiovascular Patients: Diagnosis and Management
Chest, February 1, 2005; 127(2_suppl): 46S - 52S.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. T. Gurbuz, W. G. Elliott, and A. A. Zia
Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines
Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 138 - 149.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. B. Clayton, J. R. Acsell, A. J. Crumbley III, A. G. Shackelford, and W. E. Uber
Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia
Ann. Thorac. Surg., December 1, 2004; 78(6): 2167 - 2169.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. E. Warkentin and A. Greinacher
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 311S - 337S.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
L. Shore-Lesserson
New anticoagulants and antiplatelet agents
Can J Anesth, June 1, 2004; 51(suppl_1): R9 - R9.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. F. Merry, P. J. Raudkivi, N. G. Middleton, J. M. McDougall, P. Nand, B. P. Mills, B. J. Webber, C. M. Frampton, and H. D. White
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery
Ann. Thorac. Surg., March 1, 2004; 77(3): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. Warkentin and A. Greinacher
Heparin-induced thrombocytopenia and cardiac surgery
Ann. Thorac. Surg., December 1, 2003; 76(6): 2121 - 2131.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Carrier
Reply to the Editor:
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2109 - 2109.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. A. Baciewicz Jr
Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2108 - 2109.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. E. Warkentin and A. Greinacher
Heparin-induced thrombocytopenia and cardiac surgery
Ann. Thorac. Surg., August 1, 2003; 76(2): 638 - 648.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.